共 50 条
- [41] Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (02): : 214 - 223
- [49] Protein kinase C activity and TCDD-mediated CYP1A1 gene expression. FASEB JOURNAL, 2001, 15 (04): : A512 - A512